NDC product
Conjupri
NDC 24075-0411 · CSPC Ouyi Pharmaceutical Co. Ltd
Key facts
| Product NDC | 24075-0411 |
|---|---|
| Proprietary name | Conjupri |
| Nonproprietary name | levamlodipine |
| Substances | LEVAMLODIPINE MALEATE |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | CSPC Ouyi Pharmaceutical Co. Ltd |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Application number | NDA212895 |
| Marketing start | Oct 8, 2021 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: